{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T19:18:47Z","timestamp":1785352727408,"version":"3.55.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.coph.2025.102527","type":"journal-article","created":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T14:49:19Z","timestamp":1745678959000},"page":"102527","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Fitness in acute myeloid leukemia, state of the art and future directions"],"prefix":"10.1016","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2855-8121","authenticated-orcid":false,"given":"Raffaele","family":"Palmieri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Maurillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Ilaria","family":"Del Principe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano","family":"Venditti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Buccisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2025.102527_bib1","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1182\/blood-2005-09-3724","article-title":"Age and acute myeloid leukemia","volume":"107","author":"Appelbaum","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.coph.2025.102527_bib2","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3390\/cancers12010120","article-title":"Therapeutic choice in older patients with acute myeloid leukemia: a matter of fitness","volume":"12","author":"Palmieri","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.coph.2025.102527_bib3","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/ajh.26079","article-title":"Determination of fitness and therapeutic options in older patients with acute myeloid leukemia","volume":"96","author":"Cortes","year":"2021","journal-title":"Am J Hematol"},{"key":"10.1016\/j.coph.2025.102527_bib4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/10428194.2021.1973669","article-title":"Patient characteristics, treatment patterns, and mortality in elderly patients newly diagnosed with acute myeloid leukemia meeting ineligibility criteria for high intensity chemotherapy","volume":"63","author":"Shuling","year":"2022","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.coph.2025.102527_sref5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/17474086.2023.2185603","article-title":"Assessing eligibility for treatment in acute myeloid leukemia in 2023","volume":"16","author":"Venditti","year":"2023","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.coph.2025.102527_bib6","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/bjh.17213","article-title":"Temporal changes in survival among adult patients with acute myeloid leukaemia in the period 2000-2016: a Danish population-based study","volume":"193","author":"Jakobsen","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.coph.2025.102527_bib7","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1080\/10428194.2021.2002321","article-title":"Real-world treatment patterns and clinical outcomes in patients with AML unfit for first-line intensive chemotherapy","volume":"63","author":"Miyamoto","year":"2022","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.coph.2025.102527_bib8","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1007\/s00277-017-3150-3","article-title":"Epidemiological, genetic, and clinical characterization by age of newly diagnosed acute myeloid leukemia based on an academic population-based registry study (AMLSG BiO)","volume":"96","author":"Nagel","year":"2017","journal-title":"Ann Hematol"},{"key":"10.1016\/j.coph.2025.102527_bib9","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s11912-022-01299-9","article-title":"Older patients with acute myeloid leukemia deserve individualized treatment","volume":"24","author":"De Leeuw","year":"2022","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.coph.2025.102527_sref10","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1182\/blood.2023022611","article-title":"Determining treatment tolerance and fitness for intensive chemotherapy in older adults with AML: a call to action","volume":"143","author":"Bhatt","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.coph.2025.102527_sref11","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1038\/s41375-022-01677-z","article-title":"Comparison of scoring systems evaluating suitability for intensive chemotherapy in adults with acute myeloid leukemia-a Grand Ouest against Leukemia (GOAL) study","volume":"36","author":"Desprez","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.coph.2025.102527_bib12","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1038\/s41375-020-01058-4","article-title":"Evolving treatment patterns and outcomes in older patients (\u226560 years) with AML: changing everything to change nothing?","volume":"35","author":"Mart\u00ednez-Cuadr\u00f3n","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.coph.2025.102527_sref13","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3390\/cancers15010136","article-title":"Time for dynamic assessment of fitness in acute myeloid leukemia","volume":"15","author":"Palmieri","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.coph.2025.102527_bib14","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00277-015-2351-x","article-title":"Big data analysis of treatment patterns and outcomes among elderly acute myeloid leukemia patients in the United States","volume":"94","author":"Medeiros","year":"2015","journal-title":"Ann Hematol"},{"key":"10.1016\/j.coph.2025.102527_bib15","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0889-8588(05)70287-2","article-title":"Acute myelogenous leukemia and aging: clinical interactions","volume":"14","author":"Lancet","year":"2000","journal-title":"Hematol Oncol Clin N Am"},{"key":"10.1016\/j.coph.2025.102527_bib16","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1200\/JCO.2009.25.8616","article-title":"\"I am older, not elderly,\" said the patient with acute myeloid leukemia","volume":"28","author":"Schiffer","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.coph.2025.102527_bib17","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1182\/blood-2010-03-276485","article-title":"Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemia","volume":"116","author":"Kantarjian","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.coph.2025.102527_bib18","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1200\/JCO.2011.35.7525","article-title":"Prediction of early death after induction therapy for newly diagnosed acute myeloid leukemia with pretreatment risk scores: a novel paradigm for treatment assignment","volume":"29","author":"Walter","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.coph.2025.102527_bib19","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1200\/JCO.1994.12.3.601","article-title":"Prospective evaluation of prognostic variables from patient-completed questionnaires. North Central Cancer Treatment Group","volume":"12","author":"Loprinzi","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.coph.2025.102527_bib20","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.jgo.2022.04.005","article-title":"Integrating geriatric assessment and genetic profiling to personalize therapy selection in older adults with acute myeloid leukemia","volume":"13","author":"Bhatt","year":"2022","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.coph.2025.102527_bib21","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1080\/14656566.2018.1465562","article-title":"Advancements in the management of medically less-fit and older adults with newly diagnosed acute myeloid leukemia","volume":"19","author":"Michaelis","year":"2018","journal-title":"Expet Opin Pharmacother"},{"key":"10.1016\/j.coph.2025.102527_bib22","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chron Dis"},{"key":"10.1016\/j.coph.2025.102527_bib23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/107327481502204s04","article-title":"Management of chronic lymphocytic leukemia in the elderly","volume":"22","author":"Barrientos","year":"2015","journal-title":"Cancer Control"},{"key":"10.1016\/j.coph.2025.102527_bib24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.annonc.2020.09.019","article-title":"Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Eichhorst","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.coph.2025.102527_bib25","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1182\/blood-2014-12-615187","article-title":"Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report","volume":"125","author":"Palumbo","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.coph.2025.102527_bib26","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41408-023-00930-7","article-title":"Prognostic indices in diffuse large B-cell lymphoma: a population-based comparison and validation study of multiple models","volume":"13","author":"Jelicic","year":"2023","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.coph.2025.102527_bib27","article-title":"Comprehensive analysis of dose intensity of acute lymphoblastic leukemia chemotherapy","volume":"107","author":"Karol","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.coph.2025.102527_bib28","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1182\/blood-2012-12-471680","article-title":"Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia","volume":"121","author":"Klepin","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.coph.2025.102527_bib29","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jgo.2019.10.002","article-title":"Geriatric assessment among older adults receiving intensive therapy for acute myeloid leukemia: report of CALGB 361006 (Alliance)","volume":"11","author":"Klepin","year":"2020","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.coph.2025.102527_bib30","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3324\/haematol.2012.067892","article-title":"Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcome","volume":"98","author":"Deschler","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.coph.2025.102527_bib31","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.leukres.2013.12.018","article-title":"The relevance of a geriatric assessment for elderly patients with a haematological malignancy--a systematic review","volume":"38","author":"Hamaker","year":"2014","journal-title":"Leuk Res"},{"key":"10.1016\/j.coph.2025.102527_bib32","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000535500","article-title":"Geriatric assessment in acute myeloid leukemia","volume":"147","author":"Woods","year":"2024","journal-title":"Acta Haematol"},{"key":"10.1016\/j.coph.2025.102527_bib33","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1182\/blood.2019000758","article-title":"Gait speed, grip strength, and clinical outcomes in older patients with hematologic malignancies","volume":"134","author":"Liu","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.coph.2025.102527_bib34","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/leu.2012.303","article-title":"Consensus-based definition of unfitness to intensive and non-intensive chemotherapy in acute myeloid leukemia: a project of SIE, SIES and GITMO group on a new tool for therapy decision making","volume":"27","author":"Ferrara","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.coph.2025.102527_bib35","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1182\/blood.2020008812","article-title":"Multisite 11-year experience of less-intensive vs intensive therapies in acute myeloid leukemia","volume":"138","author":"Sorror","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.coph.2025.102527_bib36","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1200\/JCO.20.01392","article-title":"Accuracy of SIE\/SIES\/GITMO consensus criteria for unfitness to predict early mortality after intensive chemotherapy in adults with AML or other high-grade myeloid neoplasm","volume":"38","author":"Palmieri","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.coph.2025.102527_bib37","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3390\/cancers16020386","volume":"16","author":"Rossi","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.coph.2025.102527_bib38","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1007\/s00432-021-03756-7","article-title":"Patterns of undertreatment among patients with acute myeloid leukemia (AML): considerations for patients eligible for non-intensive chemotherapy (NIC)","volume":"147","author":"Hubscher","year":"2021","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.coph.2025.102527_sref39","doi-asserted-by":"crossref","DOI":"10.1016\/j.jgo.2023.101626","article-title":"Treating acute myelogenous leukemia in patients aged 70 and above: recommendations from the international society of geriatric oncology (SIOG)","volume":"15","author":"Extermann","year":"2024","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.coph.2025.102527_bib40","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1016\/S0140-6736(10)62105-8","article-title":"Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes","volume":"376","author":"Krug","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.coph.2025.102527_bib41","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/ajh.26395","article-title":"Prediction of early (4-week) mortality in acute myeloid leukemia with intensive chemotherapy","volume":"97","author":"Sasaki","year":"2022","journal-title":"Am J Hematol"},{"key":"10.1016\/j.coph.2025.102527_bib42","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1200\/EDBK_200383","article-title":"Implementation of patient-reported outcomes in routine medical care","volume":"23","author":"Basch","year":"2018","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.coph.2025.102527_bib43","article-title":"How I treat: secondary acute myeloid leukemia","author":"Green","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.coph.2025.102527_sref44","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2024025409","article-title":"Genetic risk classification for adults with AML receiving less-intensive therapies: the 2024 ELN recommendations","author":"D\u00f6hner","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.coph.2025.102527_bib45","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/S1470-2045(15)00206-5","article-title":"Prognostic value of self-reported fatigue on overall survival in patients with myelodysplastic syndromes: a multicentre, prospective, observational, cohort study","volume":"16","author":"Efficace","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.coph.2025.102527_bib46","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.jgo.2021.09.007","article-title":"Patient-reported outcomes predict overall survival in older patients with acute myeloid leukemia","volume":"13","author":"Peipert","year":"2022","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.coph.2025.102527_sref47","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11899-023-00716-5","article-title":"Unlocking the potential of artificial intelligence in acute myeloid leukemia and myelodysplastic syndromes","volume":"19","author":"Alhajahjeh","year":"2024","journal-title":"Curr Hematol Malig Rep."},{"key":"10.1016\/j.coph.2025.102527_bib48","doi-asserted-by":"crossref","first-page":"690","DOI":"10.3324\/haematol.2021.280027","article-title":"Prediction of complete remission and survival in acute myeloid leukemia using supervised machine learning","volume":"108","author":"Eckardt","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.coph.2025.102527_bib49","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/S1470-2045(15)00206-5","article-title":"Prognostic value of self-reported fatigue on overall survival in patients with myelodysplastic syndromes: a multicentre, prospective, observational, cohort study","volume":"16","author":"Efficace","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.coph.2025.102527_bib50","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11899-020-00575-4","article-title":"Artificial intelligence in hematology: current challenges and opportunities","volume":"15","author":"Radakovich","year":"2020","journal-title":"Curr Hema- tol Malig Rep"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489225000232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489225000232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T09:26:08Z","timestamp":1774517168000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489225000232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":50,"alternative-id":["S1471489225000232"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2025.102527","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fitness in acute myeloid leukemia, state of the art and future directions","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2025.102527","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102527"}}